Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125231141 | 12523114 | 1 | I | 20160125 | 20160209 | 20160701 | 20160701 | EXP | US-ASTRAZENECA-2016SE16543 | ASTRAZENECA | 117.00 | DY | F | Y | 0.80000 | KG | 20160702 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125231141 | 12523114 | 1 | PS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 40.0MG UNKNOWN | ,381425 | 0 | 40 | MG | INJECTION | ||||||
| 125231141 | 12523114 | 2 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 40.0MG UNKNOWN | ,381425 | 0 | 40 | MG | INJECTION | ||||||
| 125231141 | 12523114 | 3 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 45.0MG UNKNOWN | ,381425 | 0 | 45 | MG | INJECTION | ||||||
| 125231141 | 12523114 | 4 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 45.0MG UNKNOWN | ,381425 | 0 | 45 | MG | INJECTION | ||||||
| 125231141 | 12523114 | 5 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 57.0MG UNKNOWN | ,381425 | 0 | 57 | MG | INJECTION | ||||||
| 125231141 | 12523114 | 6 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | 57.0MG UNKNOWN | ,381425 | 0 | 57 | MG | INJECTION | ||||||
| 125231141 | 12523114 | 7 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | ,381425 | 0 | INJECTION | ||||||||
| 125231141 | 12523114 | 8 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | ,381425 | 0 | INJECTION | ||||||||
| 125231141 | 12523114 | 9 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | ,381425 | 0 | INJECTION | ||||||||
| 125231141 | 12523114 | 10 | SS | SYNAGIS | PALIVIZUMAB | 1 | Intramuscular | UNKNOWN | ,381425 | 0 | INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125231141 | 12523114 | 1 | Antiviral prophylaxis |
| 125231141 | 12523114 | 2 | Premature baby |
| 125231141 | 12523114 | 3 | Antiviral prophylaxis |
| 125231141 | 12523114 | 4 | Premature baby |
| 125231141 | 12523114 | 5 | Antiviral prophylaxis |
| 125231141 | 12523114 | 6 | Premature baby |
| 125231141 | 12523114 | 7 | Antiviral prophylaxis |
| 125231141 | 12523114 | 8 | Premature baby |
| 125231141 | 12523114 | 9 | Antiviral prophylaxis |
| 125231141 | 12523114 | 10 | Premature baby |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125231141 | 12523114 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125231141 | 12523114 | General physical health deterioration | |
| 125231141 | 12523114 | Respiratory syncytial virus bronchiolitis | |
| 125231141 | 12523114 | Respiratory tract congestion | |
| 125231141 | 12523114 | Selective eating disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125231141 | 12523114 | 1 | 20151113 | 20151113 | 0 | |
| 125231141 | 12523114 | 2 | 20151113 | 20151113 | 0 | |
| 125231141 | 12523114 | 3 | 20151214 | 20151214 | 0 | |
| 125231141 | 12523114 | 4 | 20151214 | 20151214 | 0 | |
| 125231141 | 12523114 | 5 | 20160114 | 20160114 | 0 | |
| 125231141 | 12523114 | 6 | 20160114 | 20160114 | 0 | |
| 125231141 | 12523114 | 7 | 20160211 | 20160211 | 0 | |
| 125231141 | 12523114 | 8 | 20160211 | 20160211 | 0 | |
| 125231141 | 12523114 | 9 | 20160408 | 20160408 | 0 | |
| 125231141 | 12523114 | 10 | 20160408 | 20160408 | 0 |